T helper type 1 (T H 1)-polarized immune responses, which confer protection against intracellular pathogens, are thought to be initiated by dendritic cells (DCs) that enter lymph nodes from peripheral tissues. Here we found after viral infection or immunization, inflammatory monocytes were recruited into lymph nodes directly from the blood to become CD11c + CD11b hi Gr-1 + inflammatory DCs, which produced abundant interleukin 12p70 and potently stimulated T H 1 responses. This monocyte extravasation required the chemokine receptor CCR2 but not the chemokine CCL2 or receptor CCR7. Thus, the accumulation of inflammatory DCs and T H 1 responses were much lower in Ccr2 -/-mice, were preserved in Ccl2 -/-mice and were relatively higher in CCL19-CCL21-Ser-deficient plt mutant mice, in which all other lymph node DC types were fewer in number. We conclude that blood-derived inflammatory DCs are important in the development of T H 1 immune responses.
Immune responses are initiated in lymph nodes when antigen-bearing dendritic cells (DCs) stimulate the activation and polarization of T cells 1, 2 . In the classic view, T cell activation is stimulated mainly by migratory DC populations, such as Langerhans cells, that enter lymph nodes from the periphery through the lymphatics, and most DC subtypes act like Langerhans cells 1, 2 . That view has changed with the findings that some lymph node DC subtypes arise from precursors recruited directly from the blood or only during inflammation and that in many cases, migratory DC types do not directly activate T cells in vivo [3] [4] [5] . Such findings have raised questions about which lymph node DC subtypes actually stimulate T cell activation and polarization after various immunogenic stimuli.
T helper type 1 (T H 1)-polarized T cells produce interferon-g (IFN-g) and provide protection against viruses and other intracellular pathogens. T H 1 polarization of T cells is stimulated most strongly by interleukin 12 (IL-12), which is produced by monocytes, macrophages and certain DC subtypes after activation 6 . The bioactive form of IL-12, IL-12p70, is composed of two subunits: IL-12p40, which is produced in fairly large amounts and is shared with IL-23, and IL-12p35, whose production is more tightly regulated and represents the rate-limiting step in IL-12p70 formation 7 . Among DC subtypes obtained from resting lymphoid organs, resident CD8 + DCs have the most T H 1-polarizing activity 8, 9 . However, this may not be true during infection or inflammation. During chronic cutaneous leishmania infection, peripheral 'inflammatory' DCs (derived from inflammatory Gr-1 + monocytes that enter peripheral tissues, become DCs and migrate to lymph nodes through the lymphatics) accumulate in large numbers and have robust T H 1-polarizing activity 10, 11 . Consistent with the idea that monocyte-derived DCs (moDCs) stimulate T H 1 responses, these responses are considerably impaired in mice lacking CCR2 (A000625), the chemokine receptor that mediates the migration of inflammatory monocytes [12] [13] [14] . This abnormality has been proposed to be due to a defect in the trafficking of monocytes to sites of immunization or infection 13 . However, that view is not consistent with the finding that mice lacking the main CCR2 ligand CCL2 (also called monocyte chemoattractant protein 1 (MCP-1; A001484)) have normal or enhanced T H 1 responses 15, 16 . The cause of the divergent T cell responses in Ccr2 -/-and Ccl2 -/-mice has not been determined 17 .
Inflammatory DCs in lymph nodes can arise from moDCs recruited from the lymphatics (peripheral moDCs) and from inflammatory monocytes that enter lymph nodes directly from the blood (bloodderived inflammatory DCs) 10, 11, 18, 19 . Although inflammatory monocytes have been shown to extravasate across high endothelial venules into lymph nodes and develop into DCs, the function that bloodderived inflammatory DCs may serve in antigen-specific T cell responses has not been determined 18 . Here we identify a population of CD11c + CD11b hi Gr-1 + inflammatory DCs that was the main source of both IL-12p70 production and T cell IFN-g-stimulatory activity in lymph nodes after immunization or viral infection. These inflammatory DCs arose from monocytes that entered inflamed lymph nodes directly from the blood, and their accumulation in lymph nodes required CCR2 but not CCL2 or CCR7 (A000630). Inflammatory DCs were the only DC type to accumulate in the lymph nodes of mice with the plt ('paucity of lymph node T cell') mutation, a deletion of the CCR7 ligand-encoding genes Ccl19 and Ccl21-Ser, which results in the loss of all CCL19 expression and CCL21 expression in secondary lymphoid organs 20 , leading to enhanced T H 1 responses in these mice after immunization. An absence of accumulation of inflammatory DCs accounted for the much lower T H 1 responses found in CCR2-deficient mice but not in CCL2-deficient mice.
RESULTS
Higher T cell responses in lymph nodes of plt mice We identified lymph node moDCs while examining immune-response abnormalities in plt mice. These mice have over 95% less migration of naive T cells into lymph nodes and 50-60% fewer total lymph node DCs 21, 22 . However, despite those defects, plt mice have more antigenspecific T cells and more antigen-specific T cell proliferation for at least 16 months after immunization 23, 24 . On both the BALB/c (Fig. 1a) and C57BL/6 (Fig. 1b) genetic backgrounds, plt mice showed delayed-type hypersensitivity (DTH) responses that were about twofold greater than those of wild-type mice. This enhanced response was independent of whether complete Freund's adjuvant (CFA), monophosphoryl lipid A-trehalose dicorynomycolate (Ribi) or lipopolysaccharide (LPS) was used as the adjuvant for sensitization and was also independent of the number of sensitizing immunizations ( Fig. 1c and data not shown) . The contact hypersensitivity (CHS) responses of plt mice were also much greater by day 7 and were maintained without a decrease for at least 8 weeks (Fig. 1d) . After immunization with ovalbumin (OVA) in CFA, plt mice had a sixfold higher proportion of CD4 + T cells that produced IFN-g (Fig. 1e,f) , which indicated the development of much larger T H 1 T cell responses. These enhanced T cell responses were not due to an intrinsic defect in T cells or DCs. After reciprocal bone marrow transplantation between wild-type and plt mice, the plt phenotype of enhanced DTH responses was present in plt recipients regardless of the genotype of the bone marrow donor (Fig. 1g) . In our experience, bone marrow transplantation typically leads to some decrease in DTH response relative to that of nontransplanted mice (data not shown). Like plt mice, CCR7-deficient mice have defects in the accumulation of T cells and DCs in draining lymph nodes 25 but have enhanced T cell responses in CHS assays 26 . The cause of the paradoxically greater T cell responses of plt and CCR7-deficient mice has not been determined.
At baseline, plt lymph nodes have many fewer T cells and they are mainly of the memory phenotype but show no obvious abnormalities in response to antigen stimulation 21, 23 . The frequency of CD25 + regulatory T cells among total T cells in plt lymph nodes was normal at baseline and after immunization (data not shown). Thus, T cells in plt mice seem to be normal. In contrast, total CD11c + DCs in the lymph nodes of naive plt mice had a greater capacity to stimulate the proliferation of allogeneic naive CD4 + T cells (Fig. 1h) . At 9 d after immunization, a time when the T cell-proliferative responses in plt mice are higher 23 , total lymph node DCs from plt mice, bearing only the antigen administered 9 d earlier, stimulated the robust proliferation of cells from an OVA-primed DO11.10 CD4 + T cell line, whereas DCs obtained from wild-type lymph nodes showed no such ability (Fig. 1i) . This enhanced ability to stimulate OVAexperienced T cells persisted for at least 28 d after immunization ( Fig. 1j) . These results suggest that the enhanced and prolonged T cell responses in plt mice are due at least in part to higher and prolonged activity of lymph node DCs.
Alterations in DC subset composition in plt lymph nodes To determine if the higher activity of total lymph node DCs in plt mice was due to alterations in the frequency of individual lymph node DC subtypes, we used a gating protocol (Fig. 2a) to assess the frequency of six individual DC subtypes in plt popliteal lymph nodes at baseline and after footpad immunization. Five of these DC subtypes corresponded to well described lymph node DC populations 27 . These included CD11b -B220 + plasmacytoid DCs; CD11c hi CD40 int cells (gate I), which include CD11b + CD8 -DCs and CD11b int CD8 + (CD8 + ) DCs; CD11c int CD40 hi dermis-derived DCs (gate II); and CD11c hi CD40 hi Langerhans cells (gate III). We also found a CD11c int CD11b hi CD40 int DC population (gate IV) that had the phenotype described for moDCs 11, [28] [29] [30] . These CD11c int CD40 int cells were CD11b hi , CD80 + , CD86 + , positive for major histocompatibility complex class II, CD4 + and CD8 -and expressed no CCR7 ( Fig. 2a and Supplementary Fig. 1 online) . Such cells were present in small numbers in resting wild-type lymph nodes but were difficult to discern among other cell types. The CD11c int CD40 int cells were ablated after diphtheria toxin treatment of immunized mice transgenic for the CD11c-diphtheria toxin receptor (data not shown), which confirmed their classification as DCs.
Resting lymph nodes from plt mice had 45% fewer total CD11c + cells, but this result was not uniform among DC subtypes (Fig. 2b,c) . The number of CD11c int CD40 int DCs was normal in resting plt lymph nodes, whereas the absolute number of all other DC subtypes was much lower (55-81%; Fig. 2b,d ). After subcutaneous immunization with OVA in CFA, the number of CD11c int CD40 int DCs in plt lymph nodes increased normally, whereas all other DC subtypes showed almost no change in number over the 8 d after immunization (Fig. 2d) . By day 8, all DC subtypes in plt mice other than CD11c int CD11b hi CD40 int DCs were at least 75% lower in number than those of wild-type mice (Fig. 2b,c) , which resulted in a much higher ratio of CD11c int CD11b hi CD40 int DCs to other DC subtypes (1:5 in wild-type mice versus 2:1 in plt mice). Like plt mice, Ccr7 -/-mice had normal numbers of CD11c int CD11b hi CD40 int DCs 8 d after immunization but had many fewer cells of all other DC subtypes (Fig. 2d) . Ccr7 -/-mice had a greater decrease in migratory DC types (gates II and III) than did plt mice, consistent with their more complete loss of lymphatic CCR7 activity. These findings are consistent with published studies 31 .
Because moDCs express the glycosyl phosphatidylinositol-anchored monocyte differentiation antigen Ly6C for several days after their differentiation from inflammatory monocytes, they can be identified by staining with antibody to Gr-1 (anti-Gr-1), which recognizes Ly6C and Ly6G 30 . We identified Gr-1 + DCs in lymph nodes as a subset of CD11c int CD11b hi CD40 int DCs (region IV). Gr-1 proved to be more specific than CD40 in identifying moDCs as a distinct population and we therefore used it for all subsequent experiments. In wild-type mice, CD11b hi Gr-1 + DC were rare in lymph nodes at baseline but accumulated after immunization (Fig. 3a) . In plt mice, CD11b hi Gr-1 + DCs were abundant in lymph nodes at baseline and increased considerably as a proportion of total lymph node DCs after immunization (Fig. 3a) . The absolute number of CD11b hi Gr-1 + DCs in lymph nodes was normal in plt mice at baseline and after immunization (Fig. 3b) . CD11b hi Gr-1 + DCs in plt lymph nodes were CD40 int , CD80 + , CD86 + and positive for major histocompatibility complex class II ( Supplementary Fig. 2 online). To ensure that the rapid accumulation of CD11b hi Gr-1 + DCs in lymph nodes was not a specific response to CFA immunization, we used another model of inflammation, acute viral infection. By day 5 after infection with influenza virus, the frequency of CD11b hi Gr-1 + DCs had increased sevenfold in the mediastinal lymph nodes of wild-type mice (Fig. 3c) . In plt mice, the frequency of CD11b hi Gr-1 + DCs was higher at baseline and increased considerably after viral infection (Fig. 3c) . The absolute number of CD11b hi Gr-1 + DCs in plt mediastinal lymph nodes was similar to that of wild-type mice after viral infection (Fig. 3d) . Because DC migration through the lymphatics requires CCR7 activity 32 , the preserved accumulation of CD11b hi Gr-1 + DCs in plt and Ccr7 -/-mice suggested that these cells enter lymph nodes directly from the blood as inflammatory monocytes. To determine whether DCs were able to enter inflamed plt lymph nodes through the lymphatics, we injected bone marrow-derived DCs into the footpads of wild-type and plt mice. Injected DCs accumulated in the draining popliteal lymph nodes of wild-type mice but not those of plt mice (Fig. 3e) , a finding consistent with published reports 10 . In contrast, intravenous injection of bone marrow monocytes resulted in roughly equal accumulation of donor CD11c + CD11b hi CD86 + DCs in the lymph nodes of wild-type and plt mice after 3 d (Fig. 3f) . These results suggest that the inflammatory DCs in plt lymph nodes are blood derived and do not enter lymph nodes through the lymphatics.
T H 1-stimulatory activity of inflammatory DCs
The finding that plt mice had a relatively higher frequency of CD11b hi Gr-1 + DCs suggested that these cells may stimulate T H 1 polarization. To test that idea, we purified CD11b hi Gr-1 + and CD8 + DCs from the mediastinal lymph nodes of influenza-infected C57BL/6 mice and used these cells to stimulate OVA-specific OT2 T cells in vitro. We used CD8 + DCs for comparison because they have been described as being the most potent T H 1-stimulatory DC subtype 8, 9 . CD11b hi Gr-1 + DCs induced notably more T cell-generated IFN-g than did either CD8 + DCs purified from the same lymph nodes or total DCs purified from the spleens of naive mice (Fig. 4a) . This difference in IFN-g production was not due to differences in overall T cell proliferation (Fig. 4b) or T cell survival (data not shown). To determine why lymph node CD11b hi Gr-1 + DCs had such potent IFN-g-stimulatory activity, we examined the production of IL-12 by lymph node DC subtypes. We purified individual mediastinal lymph node DC subtypes by flow cytometry 4 d after influenza infection and stimulated the cells in vitro with LPS and anti-CD40. In these conditions, CD11b hi Gr-1 + DCs, CD8 + DCs and naive splenic DCs all produced substantial amounts of IL-12p40 (Fig. 4c) . However, only CD11b hi Gr-1 + DCs produced detectable amounts of complete IL-12p70 (Fig. 4d) .
To determine the extent to which CD11b hi Gr-1 + DC actually captured antigen in vivo, we immunized mice subcutaneously with OVA conjugated to Alexa Fluor 647 in CFA and assessed the percentage of each DC subtype in lymph nodes that was positive for Alexa Fluor 647. Unexpectedly, at 3 d after immunization, the percentage of CD11b hi Gr-1 + DCs that contained labeled antigen was much higher than that of any other lymph node DC subtype (Fig. 4e,f) . In addition, CD11b hi Gr-1 + DCs seemed to capture more antigen on a per-cell basis than did other lymph node DC type, on the basis of the fluorescent intensity of Alexa Fluor 647-positive cells (Fig. 4e) . We did not detect Alexa Fluor 647 staining on either monocytes or DCs in the blood of immunized mice (Fig. 4g) , which suggested that the antigen capture by CD11b hi Gr-1 + DC occurred in the lymph node.
Accumulation of moDCs requires CCR2 but not CCL2
On the basis of the findings reported above, we concluded that monocytes enter inflamed lymph nodes directly from the blood, that they give rise to inflammatory DCs with potent T H 1-stimulatory activity and that the entry of such cells into lymph node is CCR7 independent. Because the migration of inflammatory monocytes is typically CCR2 dependent, we recognized that, if correct, this model would provide an explanation for the lower T H 1 responses of Ccr2 -/-mice. We therefore examined the accumulation of inflammatory DCs in the lymph nodes of CFA-immunized and influenza-infected mice (Fig. 5a-d) . Consistent with our hypothesis, the draining lymph nodes of immunized Ccr2 -/-mice had many fewer CD11b hi Gr-1 + DCs (Fig. 5a) . The accumulation of CD11b hi Gr-1 + DCs was also much lower in the mediastinal lymph nodes of Ccr2 -/-mice during influenza infection (Fig. 5b,d) . Notably, when we examined Ccl2 -/-mice in the same way, we found no decrease in the accumulation of CD11b hi Gr-1 + DCs (Fig. 5c,d ). This finding shows that the accumulation of CD11b hi Gr-1 + DCs in lymph nodes requires CCR2 but not CCL2. In contrast, the accumulation of DCs in footpads seems to be CCL2 dependent. Ccr2 -/-and Ccl2 -/-mice had similarly lower numbers of CD11c + CD11b + DCs in the footpads 3 d after CFA injection (Fig. 5e) .
To confirm that the difference in the accumulation of inflammatory DCs in Ccr2 -/-and Ccl2 -/-mice was due to a difference in the trafficking of inflammatory monocytes, we examined the accumulation of bone marrow monocytes in lymph nodes 2 h after intravenous injection. To stimulate inflammation, we injected mice in the hind footpad with OVA plus CFA and, 72 h later, injected labeled Gr-1 + bone marrow monocytes into the tail vein. When injected into 
test (d)). NS, not significant. (h-j) ELISA of CCR2 ligands (key) in footpads (h) and popliteal lymph nodes (i) after footpad injection of
OVA in CFA, and in mediastinal lymph nodes after influenza infection (j; n ¼ 3-4 mice, h-j). *, P o 0.05; **, P o 0.005; ***, P o 0.0005; and ****, P o 0.
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wild-type mice, Ccr2 -/-monocytes migrated to the draining popliteal lymph nodes significantly less than did wild-type monocytes (Fig. 5f ).
In contrast, the migration of monocytes to lymph nodes in Ccl2 -/-mice was not less than that in wild-type mice (Fig. 5f ). In these studies, Ccr2 -/-and Ccl2 -/-mice had similarly less monocyte migration to the inflamed footpads (Fig. 5g) .
To determine why the extravasation of monocytes from blood into the lymph nodes did not require CCL2, we examined the concentrations of various CCR2 ligand proteins in resting and inflamed lymph nodes and footpads. After injection of CFA into the footpads, CCL2 was abundantly produced in the footpads, with CCL8 (MCP-2) present at much lower concentrations and no detection of CCL7 (MCP-3) or CCL12 (MCP-5; Fig. 5h ). At the same time, the draining popliteal lymph nodes had high concentrations of both CCL2 and CCL8 (Fig. 5i) . In contrast, CCL8 was the main CCR2 ligand expressed in mediastinal lymph nodes during influenza infection, with little detection of CCL2 (Fig. 5j) . These results provide a mechanistic basis for our finding that the extravasation of inflammatory monocytes was CCL2 dependent in inflamed footpads but was CCL2 independent in inflamed lymph nodes. They also account for the difference in the accumulation of inflammatory DCs in the lymph nodes of Ccr2 -/-and Ccl2 -/-mice.
Fewer T H 1-stimulatory DCs in Ccr2 -/-lymph nodes
The finding that blood-derived inflammatory DCs accumulated in the lymph nodes of Ccl2 -/-mice but not those of Ccr2 -/-mice suggested that these cells are important in stimulating T H 1 immune responses. To directly compare the T H 1 polarization of T cells in Ccr2 -/-and Ccl2 -/-mice, we examined lymph node T cells after subcutaneous immunization with OVA in CFA. After restimulation with OVA, IFN-g production by T cells from Ccr2 -/-mice was much lower, whereas T cells from Ccl2 -/-mice had more IFN-g production (Fig. 6a) . At the same time, T cells from Ccr2 -/-and Ccl2 -/-mice produced normal amounts of IL-2 (Fig. 6b) . To confirm that the lower T cell IFN-g production in Ccr2 -/-mice was due to less DC T H 1-stimulatory activity, we examined this activity in wild-type and Ccr2 -/-lymph node DC populations. To obtain sufficient cell numbers, we purified DCs from the mediastinal lymph nodes of influenza-infected mice. As noted above, CD11b hi Gr-1 + DCs purified from wild-type lymph nodes stimulated robust T cell production of IFN-g (Fig. 6c) . CD11b hi Gr-1 + DCs were not present in the lymph nodes, spleens or blood of infected Ccr2 -/-mice and therefore could not be tested. CD11b hi Gr-1 -DCs purified from wild-type lymph nodes stimulated the production of small amounts of IFN-g, showing a potency about 25% that of Gr-1 + DCs. Among CD11b hi Gr-1 -DCs purified from Ccr2 -/-lymph nodes, this activity was lower, which suggested that a portion of inflammatory DCs may have a Gr-1 -phenotype due to loss of Ly6C expression 30 . CD8 + DCs from Ccr2 -/-mice also stimulated the production of small amounts of IFN-g, with an activity similar to that of wild-type CD8 + DCs (Figs. 6c and 4a) but much less than that of CD11b hi Gr-1 + DCs. These differences in T H 1-stimulating activity were not due to differences in the stimulation of T cell proliferation (Fig. 6d) . We conclude that the diminished T H 1 responses of Ccr2 -/-mice were due to an absence of T H 1-stimulatory inflammatory DCs in inflamed lymph nodes.
DISCUSSION
Evidence suggests that many DC subtypes act together to stimulate T cell responses. Resident lymph node DCs present antigen that drains to lymph nodes and stimulate the initial steps of T cell activation, including higher CD69 expression and more retention in lymph nodes 33, 34 . Migratory DCs transport large amounts of antigen to lymph nodes and stimulate the next steps of T cell activation, which are IL-2 production and proliferation 33, 34 . Both of these DC activities are needed to stimulate robust T cell proliferation and the generation of effector responses 33, 34 . As immune stimulation continues, monocytes recruited to peripheral sites develop into inflammatory DCs, which migrate to lymph nodes to provide a continuing stimulus for T cell proliferation or polarization 11 .
Here we have shown that an additional lymph node DC type, the blood-derived inflammatory DC, serves a key function in the development of acute T cell responses, mainly by stimulating T cell polarization. Blood-derived inflammatory DCs appear in lymph nodes as CD11c + CD40 int CD11b hi Gr-1 + cells that accumulate early after a T H 1-polarizing stimulus, capture antigen, produce large amounts of IL-12p70 and stimulate IFN-g production by CD4 + T cells much more potently than do other lymph node DC subtypes. Our findings indicate that CD11c + CD40 int CD11b hi Gr-1 + DCs arise from monocytes that enter lymph nodes directly from the blood. The accumulation of inflammatory DCs in lymph nodes required CCR2 but not CCL2 or CCR7, which provides an explanation for the defects in T cell polarization in Ccr2 -/-, Ccl2 -/-and plt mice. These defects have been recognized for some time but have been difficult to reconcile with the classic view of T cell activation strictly by lymphaticborne DCs 17 .
Our findings suggest that both CCL2 and CCL8 can stimulate monocyte extravasation from blood into lymph nodes. Consistent with the relative concentrations of these chemokines, we found that monocyte extravasation was completely CCL2 independent in mediastinal lymph nodes and was somewhat CCL2 dependent in popliteal lymph nodes (data not shown). A published study has shown that the extravasation of monocytes from blood into lymph nodes can be CCL2 dependent 19 . As reported in that paper 19 , we found little CCL2 mRNA in inflamed lymph nodes (data not shown). Because most CCL2 protein in lymph nodes is produced remotely, lymph node CCL2 concentrations and the contribution of CCL2 to the extravasation of monocytes from blood into lymph nodes probably depend on the specific inflammatory stimulus, the time after stimulation and the peripheral tissue being drained. Direct proof that CCL8 stimulates the extravasation of monocytes from blood into lymph nodes will probably require the examination of mice lacking this chemokine. We found that CCL2 was the main CCR2 ligand expressed in inflamed footpads and that the migration of inflammatory monocytes to footpads was CCL2 dependent. For this reason, Ccr2 -/-and Ccl2 -/-mice had similar defects in the accumulation of DCs in footpads and, presumably, similar alterations in lymph node DC populations derived from peripheral tissues. Thus, the presence of blood-derived inflammatory DCs seems to be the only substantial difference in the lymph node DC populations of Ccr2 -/-versus Ccl2 -/-mice. This difference is closely associated with the ability to develop T H 1 responses, which shows that blood-derived inflammatory DCs provide a T cell-polarizing activity that is sufficient for a robust T H 1 immune response. Blood-derived inflammatory DCs are probably also necessary for such responses in the conditions we used, as no other lymph node DC subtype showed a similar T H 1-stimulatory activity. However, it is possible that both Ccr2 -/-and Ccl2 -/-mice lack a peripheral DC type that would be sufficient to stimulate T H 1 polarization in the absence of blood-derived inflammatory DCs. T cell-proliferative responses were normal in Ccr2 -/-mice, which shows that bloodderived inflammatory DCs are not necessary for T cell proliferation 35 .
The immune-response abnormalities of plt mice involved defects in both T cell polarization and the contraction phase of the T cell response. The lymph nodes of plt mice had normal numbers of blood-derived inflammatory DCs but were deficient in all other, CCR7-dependent DC types. The enhanced T H 1 responses of plt mice provide additional evidence that blood-derived inflammatory DCs are sufficient for T H 1 polarization but also suggest that this response is normally modulated by one or more CCR7-dependent DC type(s). The plt mice had normal T cell-proliferative responses, which suggests that blood-derived inflammatory DCs can provide a stimulatory activity that is sufficient to drive T cell proliferation. That conclusion was supported by our finding that lymph node CD11b + Gr-1 + DCs stimulated T cell proliferation in vitro to an extent similar to that of other lymph node DC types. Studies have shown that plt mice also have considerable prolongation of T cell responses, more antigen-specific T cells and a much lower percentage of antigen-specific lymph node T cells that undergo apoptosis after immunization 23, 24 . Such findings suggest that a CCR7-dependent DC population stimulates the contraction phase of T cell responses, perhaps by inducing the apoptosis of activated T cells 36 .
Our findings suggested that inflammatory DCs capture antigen in lymph nodes, as we detected no antigen on circulating monocytes. This may occur through the capture of antigen in free form in lymph nodes or through transfer from other DCs 5, 37 . On the basis of the different responses of plt and Ccr7 -/-mice, we speculate that inflammatory DCs obtain antigen through transfer from other DC types. Studies have shown that plt mice have low expression of CCL21 on lymphatics and show some migration of Langerhans and dermal DCs to lymph nodes 20, 22 . In contrast, Ccr7 -/-mice lack all CCR7 activity and have almost no detectable migration of these cell types 25 . Because plt and Ccr7 -/-mice would be expected to have normal amounts of free antigen in lymph nodes, any differences in antigen trafficking to lymph nodes are probably due to transport by migratory DCs. The activity of Ccr7 -/-migratory DCs is not sufficient to support the proliferation of CD4 + T cells after immunization with OVA-CFA 34 . Similarly, during influenza infection, antigen transport in Ccr7 -/-mice is insufficient to support the proliferation of CD8 + T cells and results in only limited CD4 + T cell responses 38 . Consistent with our findings, those limited CD4 + T cell responses include much more IFN-g production by T cells 38 . The amount of antigen in lymph nodes needed to stimulate T cell activation is very low but has a sharp threshold that can be achieved with very few DCs 39 . It seems that this threshold is reached in plt mice but in some cases is not reached in Ccr7 -/-mice. The enhanced T cell responses in plt mice seem to be due to their greater proportion of blood-derived inflammatory DCs, which suggests that differences in the immune responses of plt and Ccr7 -/-mice are due to the delivery of antigen to these cells by migratory DC types.
In the conditions we used, blood-derived inflammatory DCs had a potent T H 1-stimulatory activity, probably due to their robust production of IL-12p70. CD11b + Gr-1 + DCs obtained from IL-12p35-deficient mice failed to stimulate IFN-g production by T cells in vitro (data not shown). These cells may also stimulate the T H 2 polarization of T cells. Inflammatory DCs stimulate T H 2 responses after intraperitoneal injection of OVA in the adjuvant alum 40 . Two publications 41, 42 and our own unpublished findings have shown that plt mice have enhanced T H 2 responses when given a T H 2-polarizing stimulus. At present, it is not clear whether the enhanced T H 2 responses of plt mice are due to more T H 2-polarizing activity or to a diminished ability to modulate immune responses. T H 2 responses are not lower in Ccr2 -/-mice, which shows that blood-derived inflammatory DCs are not necessary for T H 2 polarization. Delineation of the specific function of blood-derived inflammatory DCs, relative to that of other DC types, in regulating immune responses will have important implications for efforts to enhance or inhibit these responses in clinical settings.
METHODS
Mice. BALB/c, C3H/He and C57BL/6 mice were from Charles River Laboratories. CD11c-DTR, CD45.1, DO11.10, OT2, Ccr2 -/-and Ccl2 -/-mice were from The Jackson Laboratory. DDD/1-plt mice were backcrossed to BALB/c mice ten times and to C57BL/6 mice eleven times 23 and were maintained at Duke University Medical Center and Toho University School of Medicine. All mice were kept in specific pathogen-free conditions and were used at 7-15 weeks of age. Mice were immunized subcutaneously at two sites on the back with 100 mg chicken OVA (Sigma-Aldrich) in Ribi adjuvant (SigmaAldrich) or in a 1:1 emulsion of PBS and CFA (Difco or Sigma-Aldrich), or were immunized in the footpad with 10-20 mg OVA in CFA. For influenza infection, mice were anesthetized by intraperitoneal injection of ketamine and xylazine (100 mg and 10 mg, respectively, per kg body weight), then were infected intranasally with H1N1 influenza virus, strain A/Puerto Rico/8/34 (PR8; VR-95; American Type Culture Collection) with 30 ml of 5 Â 10 5 of the half-maximal tissue culture infectious dose of virus per ml per mouse. The body weight of infected mice was monitored daily. All experiments were done according to institutional guidelines and were approved by the Institutional Animal Care and Use Committee of Duke University.
Antibodies. Purified monoclonal antibodies specific for the following mouse antigens were used (biotinylated or conjugated to Alexa Fluor 488, allophycocyanin, fluorescein isothiocyanate, phycoerythrin, phycoerythrin-indodicarbocyanine, phycoerythrin-carbocyanine 5. For the purification of total CD11c + DCs, the low-density cells from lymph nodes were incubated with biotinylated anti-CD11c and streptavidinconjugated MACS beads (Miltenyi), then were positively sorted on a magneticactivated cell sorter according to the manufacturer's instruction (Miltenyi). Over 98% of the sorted cells were CD11c + . For the purification of DC subsets, cells were sorted as described 43 . Low-density lymph node cells were stained for 30 min at 0 1C with monoclonal anti-CD3, anti-CD8a, anti-CD11b, anti-CD11c, anti-CD19 and anti-Ly6C/G. After two washes, individual DC subsets among CD11c + CD3 -CD19 -cells were sorted on a FACSVantage (Becton Dickinson). Cell purity after sorting was about 85-95%.
T cell culture and proliferation assays. Naive CD4 + T cells from DO11.10, OT2 or C3H/He mice were prepared as described 43 . Single-cell suspensions of pooled lymph nodes and spleens were incubated for 30 min at 0 1C with biotinylated anti-CD8, anti-CD11b, anti-CD11c, anti-CD16/32, anti-CD19, anti-CD25, anti-B220, anti-CD49b, anti-Ly6/G and anti-Ter119 (all at a concentration of 1.25 mg/ml), then for 20 min at 0 1C with streptavidinconjugated MACS beads (Miltenyi), were negatively selected on a MACS LD column, and were centrifuged on Percoll (50% and 60%; Invitrogen). Cells at the 50%-60% Percoll interface were collected as naive CD4 + T cells. Over 97% of the purified cells were CD4 + , and over 90% were CD45RB + CD44 int-lo . Cells were cultured in U-bottomed 96-well plates at 37 1C with 5% CO 2 in cRPMI-10 medium (RPMI-1640 medium (Invitrogen), 10% (vol/vol) FCS (Gibco), 20 mM HEPES, pH 7.4, 55 mM 2-mercaptoethanol (Sigma-Aldrich), 50 U/ml of penicillin and 50 mg/ml of streptomycin). For preparation of the OVAspecific T cell line, 5 Â 10 5 naive DO11.10 CD4 + T cells were cultured in 24-well plates with 1 mM OVA peptide (amino acids 323-339) and 1 Â 10 6 irradiated (30 Gy) splenic low-density cells in 2 ml cRPMI-10 medium supplemented with IL-2 (20 U/ml; Shionogi). The stimulated CD4 + T cells were maintained in cRPMI-10 medium supplemented with IL-2 (10 U/ml) and were restimulated every 2-3 weeks with 1 mM OVA peptide (amino acids 323-339) plus 1 Â 10 6 spleen cells. OVA-primed CD4 + T cells were allowed to 'rest' for at least 6 d before use.
For proliferation assays, 1 Â 10 5 naive CD4 + T cells or 5 Â 10 4 cells from the DO11.10 T cell line were cultured together with freshly isolated and irradiated DCs for 3-6 d in U-bottomed 96-well plates in 200 ml cRPMI-10 medium, and T cell proliferation measured either by pulsing of cells with 1.25 mCi Restimulation of total lymph node cells with OVA. Total cells were isolated from the draining lymph nodes of immunized wild-type, plt, Ccr2 -/-or Ccl2 -/-mice and were cultured for 48 h in the presence of OVA (1 mg/ml). Cytokine production was measured by intracellular staining for IFN-g and by analysis of IL-2 and IFN-g in supernatants by ELISA. For ELISA, aliquots of T cell culture supernatants were collected before labeling with [ 3 H]thymidine or BrdU and were assayed with an Opt-EIA kit according to the manufacturer's instructions (BD Bioscience).
DTH and CHS assays. At 7 d after subcutaneous immunization with OVA-CFA or OVA-Ribi, immunized and naive mice were injected intracutaneously in the right ear with 10 ml PBS alone and in left ear with 10 ml PBS and 25 mg OVA. Ear thickness was measured with a Peacock dial thickness gauge (Ozaki MFG) before and 24 h after elicitation. Ear swelling was calculated as the difference in thickness at 0 h and 24 h. Reciprocal bone marrow transplants between BALB/c and BALB/c-plt mice were done as described 44 . Bone marrow cells (1 Â 10 7 ) were injected intravenously into g-irradiated recipient mice (8.5 Gy) 30 d before immunization. For CHS assays, mice were sensitized on their shaved abdomens with 50 ml oxazolone (100 mg/ml in vehicle (acetone and olive oil at a ratio of 4:1)). Then, 7-56 d later, the right ear was challenged with 10 ml oxazolone (10 mg/ml in vehicle) and the left ear was challenged with vehicle alone. Ear thickness was measured before elicitation and at 24 h and ear swelling was calculated as described above.
DC migration assay. BALB/c bone marrow-derived DCs were prepared by culture of bone marrow cells at a density of 1 Â 10 6 cells per ml in RPMI-1640 medium, 10% (vol/vol) FBS and 3.3 ng/ml of granulocyte-macrophage colony-stimulating factor (R&D Systems), then were collected at day 9, labeled with the cytosolic dye CFSE (carboxyfluorescein diacetate succinimidyl diester) and injected into footpads (8 Â 10 5 cells per pad) of anesthetized BALB/c or BALB/c-plt mice. Before or 1-3 d after DC injection, draining popliteal lymph nodes were collected and prepared as described above, and CFSE + CD11c + autofluorescence-negative cells were counted by flow cytometry.
Monocyte purification, transfer and migration. Bone marrow cells were collected in RPMI-1640 medium with 10% (vol/vol) FBS, were prepared as single-cell suspensions and were washed. Red blood cells were lysed with ammonium chloride-potassium bicarbonate buffer, and the remaining cells were incubated for 30 min at 0 1C with biotinylated anti-CD3, anti-CD4, anti-CD8, anti-CD11c, anti-CD19, anti-Sca-1, anti-B220, anti-c-Kit, anti-I-A b and anti-Ter119, and fluorescein isothiocyanate-labeled anti-CCR3 and anti-Ly6G (all at a concentration of 1.25 mg/ml), followed by incubation for 20 min at 0 1C with streptavidin-conjugated and anti-fluorescein isothiocyanate MACS beads (Miltenyi) and negative selection over a MACS LD or LS column. The resulting monocytes were labeled with CFSE, and 3 Â 10 6 to 6 Â 10 6 cells were injected intravenously into recipient mice 3 d after footpad injection of 10 ml OVA in CFA. Then, 2 h later, the popliteal lymph nodes and footpads of recipient mice were collected, digested with collagenase A and DNase I, processed for DC isolation as described above with an 18% (vol/vol) Nycodenz gradient and analyzed by flow cytometry. Donor monocytes were identified as CFSE + Ly6C hi CD11b + Ly6G -autofluorescencenegative cells.
OVA antigen uptake by DC and monocytes. C57BL/6 mice were immunized on the back with OVA in CFA (100 mg per site; Sigma) or
